Antigone Kotsaki Selected Research

Antigone Kotsaki Research Topics

Disease

9	Sepsis (Septicemia) 01/2021 - 01/2010
7	Infections 01/2022 - 03/2012
5	COVID-19 01/2022 - 10/2020
3	Ventilator-Associated Pneumonia 01/2022 - 04/2014
3	Shock 04/2014 - 01/2010
3	Septic Shock (Toxic Shock Syndrome) 04/2014 - 06/2012
2	Critical Illness (Critically Ill) 01/2022 - 06/2012
2	Pyelonephritis 01/2022 - 01/2010
2	Disease Progression 01/2022 - 10/2021
2	Intraabdominal Infections 01/2022 - 01/2010
2	Respiratory Insufficiency (Respiratory Failure) 10/2021 - 10/2020
2	Human Influenza (Influenza) 10/2020 - 03/2012
1	Healthcare-Associated Pneumonia 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Coinfection 01/2022
1	Communicable Diseases (Infectious Diseases) 06/2021
1	Lymphopenia (Lymphocytopenia) 10/2020
1	Inflammation (Inflammations) 10/2020
1	Macrophage Activation Syndrome 10/2020
1	Bacteremia 11/2018
1	Inguinal Hernia (Direct Inguinal Hernia) 05/2018
1	Varicose Veins (Varicose Vein) 05/2018
1	Multiple Organ Failure (MODS) 08/2013
1	Paralysis (Palsy) 08/2013
1	Disseminated Intravascular Coagulation 09/2012
1	Necrosis 06/2012
1	Wounds and Injuries (Trauma) 08/2010
1	Hidradenitis Suppurativa 06/2010

Drug/Important Bio-Agent (IBA)

3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 10/2021
3	Angiopoietin-2IBA 05/2015 - 11/2012
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 10/2020
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2021 - 10/2021
2	PlasminogenIBA 10/2021 - 10/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2021 - 08/2013
2	ProcalcitoninIBA 06/2021 - 11/2018
2	HLA-DR Antigens (HLA-DR)IBA 10/2020 - 01/2010
2	CytokinesIBA 10/2020 - 11/2012
2	Interleukin-6 (Interleukin 6)IBA 10/2020 - 06/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 03/2012
2	Interleukin-10 (Interleukin 10)IBA 08/2013 - 06/2012
2	LipopolysaccharidesIBA 08/2013 - 11/2012
1	meropenem and vaborbactamIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021
1	Urokinase Plasminogen Activator ReceptorsIBA 10/2021
1	C-Reactive ProteinIBA 06/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	VaccinesIBA 10/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	Carbapenems (Carbapenem Antibiotics)IBA 11/2018
1	Sevoflurane (Ultane)FDA LinkGeneric 05/2018
1	Propofol (Diprivan)FDA LinkGeneric 05/2018
1	Clarithromycin (Biaxin)FDA LinkGeneric 04/2014
1	EndotoxinsIBA 08/2013
1	salicylhydroxamic acid (SHAM)IBA 08/2013
1	Ertapenem (Invanz)FDA Link 08/2013
1	Interleukin-17 (Interleukin 17)IBA 08/2013
1	Immunoglobulin M (IgM)IBA 09/2012
1	ThrombomodulinIBA 09/2012
1	Immunoglobulins (Immunoglobulin)IBA 09/2012
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 06/2012
1	Interleukin-8 (Interleukin 8)IBA 06/2012
1	EnzymesIBA 06/2012
1	InterleukinsIBA 06/2012
1	DNA (Deoxyribonucleic Acid)IBA 03/2012
1	A-factor (Streptomyces)IBA 03/2011
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 08/2010
1	SolutionsIBA 08/2010
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 08/2010
1	Eicosapentaenoic AcidIBA 08/2010
1	Etanercept (Enbrel)FDA Link 06/2010
1	Monoclonal AntibodiesIBA 01/2010

Therapy/Procedure

1	Immunotherapy 01/2022
1	Epidural Anesthesia 05/2018
1	General Anesthesia 05/2018
1	Therapeutics 08/2013
1	Ligation 11/2011
1	Punctures 11/2011